IW
HUMA icon

Imprint Wealth’s Humacyte HUMA Stock Holding History

Imprint Wealth’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.8K Hold
16,363
– – 0.05% 117
2026
Q1 		$9.93K Hold
16,363
– – 0.05% 124
2025
Q4 		$15.7K Sell
16,363
-2,545
-13% -$3.6K 0.07% 106
2025
Q3 		$32.9K Buy
+18,908
New +$37K 0.11% 90
2024
Q1 		$70.2K Sell
23,321
-16,382
-41% -$55.1K 0.02% 298
2023
Q4 		$116K Sell
39,703
-7,369
-16% -$18.9K 0.09% 154
2023
Q3 		$138K Sell
47,072
-48,574
-51% -$161K 0.12% 147
2023
Q2 		$326K Sell
95,646
-161,473
-63% -$582K 0.21% 134
2023
Q1 		$938K Buy
+257,119
New +$731K 0.62% 43

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Imprint Wealth's HUMA Position: Q2 2026 in Review

Imprint Wealth held its Humacyte (HUMA) position steady in Q2 2026 at 16,363 shares worth $12.8K. The position accounts for 0.05% of the portfolio, ranked #117.

Imprint Wealth first reported a position in HUMA in Q1 2023 and has held it in 9 quarters since. The position peaked at $938K in Q1 2023. 163 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Imprint Wealth held 16,363 shares of Humacyte worth $12.8K as of Q2 2026.
  • Imprint Wealth left its Humacyte share count unchanged in Q2 2026.
  • Humacyte made up 0.05% of Imprint Wealth's portfolio in Q2 2026, its #117 holding.
  • Imprint Wealth first reported a position in Humacyte in Q1 2023 and has held it in 9 quarters since.
  • Imprint Wealth's Humacyte position peaked at $938K in Q1 2023.
  • 163 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Imprint Wealth's 13F filing for Q2 2026, filed 14 Aug 2026.